A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection. Academic Article uri icon

Overview

abstract

  • While the development of different vaccines slowed the dissemination of SARS-CoV-2, the occurrence of breakthrough infections has continued to fuel the COVID-19 pandemic. To secure at least partial protection in the majority of the population through 1 dose of a COVID-19 vaccine, delayed administration of boosters has been implemented in many countries. However, waning immunity and emergence of new variants of SARS-CoV-2 suggest that such measures may induce breakthrough infections due to intermittent lapses in protection. Optimizing vaccine dosing schedules to ensure prolonged continuity in protection could thus help control the pandemic. We developed a mechanistic model of immune response to vaccines as an in silico tool for dosing schedule optimization. The model was calibrated with clinical data sets of acquired immunity to COVID-19 mRNA vaccines in healthy and immunocompromised participants and showed robust validation by accurately predicting neutralizing antibody kinetics in response to multiple doses of COVID-19 mRNA vaccines. Importantly, by estimating population vulnerability to breakthrough infections, we predicted tailored vaccination dosing schedules to minimize breakthrough infections, especially for immunocompromised individuals. We identified that the optimal vaccination schedules vary from CDC-recommended dosing, suggesting that the model is a valuable tool to optimize vaccine efficacy outcomes during future outbreaks.

publication date

  • July 10, 2023

Research

keywords

  • COVID-19
  • COVID-19 Vaccines

Identity

PubMed Central ID

  • PMC10371350

Scopus Document Identifier

  • 85164273500

Digital Object Identifier (DOI)

  • 10.1172/jci.insight.169860

PubMed ID

  • 37227783

Additional Document Info

volume

  • 8

issue

  • 13